Next GEN Act of 2026

Joseph D. Morelle

Democrat · NY · Representative

Source: Congress.gov · FEC

• August Pfluger (R-TX-11)Original· 2026-05-15
• Josh Gottheimer (D-NJ-5)Original· 2026-05-15
• Thomas H. Kean, Jr. (R-NJ-7)Original· 2026-05-15

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

2026-05-15

Source: Congress.gov

The federal government negotiates drug prices for Medicare beneficiaries, and this bill would change which engineered cyclic peptide drugs qualify as "single source drugs" eligible for that negotiation program. This adjustment could affect which medications are subject to price negotiations and potentially impact both patients' drug costs and pharmaceutical companies that manufacture these specific types of drugs. The bill is currently being reviewed by two congressional committees to determine how it fits within their areas of responsibility.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 8857 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 8857 To amend title XI of the Social Security Act to adjust which engineered cyclic peptides are qualifying single source drugs for purposes of the Drug Price Negotiation Program. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES May 15, 2026 Mr. Morelle (for himself, Mr. Gottheimer, Mr. Pfluger, and Mr. Kean) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned _______________________________________________________________________ A BILL To amend title XI of the Social Security Act to adjust which engineered cyclic peptides are qualifying single source drugs for purposes of the Drug Price Negotiation Program. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Next Generation Medicines Act of 2026'' or the ``Next GEN Act of 2026''. SEC. 2. ADJUSTING RULES FOR ENGINEERED CYCLIC PEPTIDES UNDER DRUG PRICE NEGOTIATION PROGRAM. (a) In General.--Section 1192(e) of the Social Security Act (42 U.S.C. 1320f-1(e)) is amended-- (1) in paragraph (1)(A)(ii), by inserting ``(or, in the case of an engineered cyclic peptide (as defined in paragraph (5)), 11 years)'' after ``7 years''; and (2) by adding at the end the following new paragraph: ``(5) Engineered cyclic peptide defined.--In this subsection, the term `engineered cyclic peptide' means a polymer that-- ``(A) is composed principally of amino acids; ``(B) contains not less than 1 cyclic structure produced through head-to-tail cyclization, head-to- side-chain cyclization, side-chain-to-tail cyclization, or side-chain-to-side-chain cyclization; ``(C) contains not more than 40 amino acids; ``(D) was identified for development using a genetically encoded library screening method; ``(E) is not naturally derived; and ``(F) is orally administered, inhaled, or otherwise self-administered.''. (b) Effective Date.--The amendments made by this section shall apply with respect to lists published under section 1192(a) of the Social Security Act (42 U.S.C. 1320f-1(a)) on or after the date of the enactment of this section. <all>

• HR8738FEC Administrative Improvements Act
  Passed House · 2026-07-14
• HR9440State Firearms Dealer Licensing Enhancement Act
  Referred to Committee · 2026-06-24
• HR9290Supreme Court Justice Circuit Riding Act
  Referred to Committee · 2026-06-11
• HR8984Respect Our Communities Act
  Referred to Committee · 2026-05-22